Abstract
The aim of this study was to gain insight into treatment costs associated with allogeneic hematopoietic cell transplantation (AlloHCT), graft-versus-host disease (GVHD) and veno-occlusive disease (VOD) associated with the treatment of acute myeloid leukemia (AML) from a Social Security perspective in Argentina.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
